AB50200
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1g | 95% | in stock | $19.00 | $13.00 | - + | |
5g | 95% | in stock | $47.00 | $33.00 | - + | |
25g | 95% | in stock | $177.00 | $124.00 | - + | |
100g | 95% | in stock | $538.00 | $377.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AB50200 |
Chemical Name: | 4-Piperidinobenzaldehyde |
CAS Number: | 10338-57-5 |
Molecular Formula: | C12H15NO |
Molecular Weight: | 189.2536 |
MDL Number: | MFCD00778395 |
SMILES: | O=Cc1ccc(cc1)N1CCCCC1 |
NSC Number: | 156549 |
Complexity: | 179 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 2 |
XLogP3: | 2.9 |
4-(Piperidin-1-yl)benzaldehyde is a versatile compound commonly used in chemical synthesis for its unique properties and reactivity. In organic chemistry, this compound serves as a valuable building block in the synthesis of various pharmaceuticals, agrochemicals, and fine chemicals.One of the key applications of 4-(Piperidin-1-yl)benzaldehyde is its role as a starting material in the synthesis of heterocyclic compounds. By reacting with different nucleophiles or electrophiles, it can undergo a variety of transformations to generate complex structures with diverse functionalities. This compound is particularly useful in forming fused heterocycles, which are prevalent in many bioactive molecules.Furthermore, 4-(Piperidin-1-yl)benzaldehyde is often employed in the preparation of ligands for coordination chemistry or as a precursor for the synthesis of chiral compounds. Its ability to undergo selective functionalization reactions makes it a valuable tool for accessing stereochemically complex molecules with high enantiomeric purity.Overall, the versatility and reactivity of 4-(Piperidin-1-yl)benzaldehyde make it a valuable component in the toolbox of synthetic chemists for building structurally diverse and biologically active compounds.
Acta crystallographica. Section E, Structure reports online 20101101
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Journal of medicinal chemistry 20020523